Lexicon Pharmaceuticals
LXRX
LXRX
121 hedge funds and large institutions have $582M invested in Lexicon Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
1.18% less ownership
Funds ownership: 99.48% → 98.3% (-1.2%)
17% less capital invested
Capital invested by funds: $697M → $582M (-$115M)
74% less call options, than puts
Call options by funds: $1.36M | Put options by funds: $5.14M
Holders
121
Holding in Top 10
2
Calls
$1.36M
Puts
$5.14M
Top Buyers
| 1 | +$15.3M | |
| 2 | +$5.2M | |
| 3 | +$2.5M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.88M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$975K |
Top Sellers
| 1 | -$10.2M | |
| 2 | -$5.09M | |
| 3 | -$3.38M | |
| 4 |
SGA
Sector Gamma AS
Oslo,
Norway
|
-$2.7M |
| 5 |
TRSOTSOK
Teachers Retirement System of the State of Kentucky
Frankfort,
Kentucky
|
-$2.13M |